NAV

3-Dehydroshikimate

Identification

Generic Name
3-Dehydroshikimate
DrugBank Accession Number
DB04347
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 172.1354
Monoisotopic: 172.037173366
Chemical Formula
C7H8O5
Synonyms
Not Available
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
U3-dehydroquinate dehydrataseNot AvailableStaphylococcus aureus (strain MRSA252)
U3-dehydroquinate dehydrataseNot AvailableStreptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as cyclohexenones. These are compounds containing a cylohexenone moiety, which is a six-membered aliphatic ring that carries a ketone and has one endocyclic double bond.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbonyl compounds
Direct Parent
Cyclohexenones
Alternative Parents
Secondary alcohols / 1,2-diols / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives
Substituents
1,2-diol / Alcohol / Aliphatic homomonocyclic compound / Carboxylic acid / Carboxylic acid derivative / Cyclohexenone / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic oxide / Secondary alcohol
Molecular Framework
Aliphatic homomonocyclic compounds
External Descriptors
alpha,beta-unsaturated monocarboxylic acid, 4-oxo monocarboxylic acid, 5-hydroxy monocarboxylic acid, 4-hydroxy monocarboxylic acid (CHEBI:30918)
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
SLWWJZMPHJJOPH-PHDIDXHHSA-N
InChI
InChI=1S/C7H8O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,5-6,9-10H,2H2,(H,11,12)/t5-,6-/m1/s1
IUPAC Name
(4S,5R)-4,5-dihydroxy-3-oxocyclohex-1-ene-1-carboxylic acid
SMILES
O[C@@H]1CC(=CC(=O)[C@H]1O)C(O)=O

References

General References
Not Available
KEGG Compound
C02637
PubChem Compound
439774
PubChem Substance
46507545
ChemSpider
388830
ChEBI
30918
ZINC
ZINC000100018238
PDBe Ligand
3DS
Wikipedia
3-Dehydroshikimic_acid
PDB Entries
4gug / 4guh / 6hqv / 6hs9

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility137.0 mg/mLALOGPS
logP-1.2ALOGPS
logP-1Chemaxon
logS-0.1ALOGPS
pKa (Strongest Acidic)3.02Chemaxon
pKa (Strongest Basic)-3.3Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area94.83 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity38.19 m3·mol-1Chemaxon
Polarizability14.91 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.8153
Blood Brain Barrier-0.5791
Caco-2 permeable-0.7735
P-glycoprotein substrateNon-substrate0.5902
P-glycoprotein inhibitor INon-inhibitor0.9526
P-glycoprotein inhibitor IINon-inhibitor0.9974
Renal organic cation transporterNon-inhibitor0.9388
CYP450 2C9 substrateNon-substrate0.8455
CYP450 2D6 substrateNon-substrate0.9011
CYP450 3A4 substrateNon-substrate0.6261
CYP450 1A2 substrateNon-inhibitor0.9537
CYP450 2C9 inhibitorNon-inhibitor0.964
CYP450 2D6 inhibitorNon-inhibitor0.9488
CYP450 2C19 inhibitorNon-inhibitor0.965
CYP450 3A4 inhibitorNon-inhibitor0.941
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9773
Ames testNon AMES toxic0.8957
CarcinogenicityNon-carcinogens0.9479
BiodegradationReady biodegradable0.8661
Rat acute toxicity1.7570 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9814
hERG inhibition (predictor II)Non-inhibitor0.9628
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (1 MEOX; 3 TMS)GC-MSsplash10-001r-4951000000-73e5d4c38702a9a74934
GC-MS Spectrum - GC-MS (1 MEOX; 3 TMS)GC-MSsplash10-05as-2981000000-48228f5a995cc5391fde
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-03dl-9800000000-4262d1ae298a71a287f4
MS/MS Spectrum - , negativeLC-MS/MSsplash10-056r-1900000000-78f25cc3fd642b56e1ec
MS/MS Spectrum - , positiveLC-MS/MSsplash10-022i-2900000000-0cfcedb79843656d9142
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0axr-0900000000-533615c267c71bbbe2c9
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00fr-0900000000-6cbbf6e65f35dfb3085c
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0kdi-2900000000-f32bd71c1f89ad14f1dd
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-016r-0900000000-7bbe75570acdfcd0db5b
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9300000000-34b6729a4b5030413ecf
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0mji-9300000000-9f9ee5ba7fd17c283c5a
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-137.6595468
predicted
DarkChem Lite v0.1.0
[M-H]-137.9189468
predicted
DarkChem Lite v0.1.0
[M-H]-132.12917
predicted
DeepCCS 1.0 (2019)
[M+H]+138.6507468
predicted
DarkChem Lite v0.1.0
[M+H]+138.0257468
predicted
DarkChem Lite v0.1.0
[M+H]+134.52473
predicted
DeepCCS 1.0 (2019)
[M+Na]+138.3975468
predicted
DarkChem Lite v0.1.0
[M+Na]+138.3384468
predicted
DarkChem Lite v0.1.0
[M+Na]+140.80666
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. 3-dehydroquinate dehydratase
Kind
Protein
Organism
Staphylococcus aureus (strain MRSA252)
Pharmacological action
Unknown
General Function
3-dehydroquinate dehydratase activity
Specific Function
Involved in the third step of the chorismate pathway, which leads to the biosynthesis of aromatic amino acids. Catalyzes the cis-dehydration of 3-dehydroquinate (DHQ) and introduces the first doubl...
Gene Name
aroD
Uniprot ID
Q6GII7
Uniprot Name
3-dehydroquinate dehydratase
Molecular Weight
27052.965 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Details2. 3-dehydroquinate dehydratase
Kind
Protein
Organism
Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145)
Pharmacological action
Unknown
General Function
3-dehydroquinate dehydratase activity
Specific Function
Catalyzes a trans-dehydration via an enolate intermediate.
Gene Name
aroQ
Uniprot ID
P15474
Uniprot Name
3-dehydroquinate dehydratase
Molecular Weight
16681.69 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52